PHARMANOVIA ENTERS NEW CHEMICAL ENTITY LICENSING AGREEMENT WITH STEALTH BIOTHERAPEUTICS TO MARKET AND FURTHER DEVELOP A POTENTIAL NOVEL TREATMENT FOR BARTH SYNDROME - News Azi
News Azi,
Basildon, UK, May 30, 2023 (GLOBE NEWSWIRE) — PRESS RELEASE – FOR BUSINESS